The purpose and significance of gastric cancer is one of the common malignant tumors in clinical traditional treatment of gastric cancer surgical resection and radiotherapy and chemotherapy, but the total efficiency of the treatment is not satisfactory, to seek new anti-cancer drugs, using a variety of effective treatment joint application, synergy and one is tumor treatment development trend. Chinese medicine, Integrative Medicine gastric prove a certain role in our clinical practice. In recent years, many researchers committed to the deep-level to explore the mechanism of action of the anti-tumor medicine, found that some Chinese medicine, particularly in the treatment of cancer in combination with other treatment tend to be better, and the side effects on the human body is relatively small, with a simple to use Western medicine may incomparable efficacy. White cardamom is a tumor suppressor characteristics of traditional Chinese medicine, the extract can enhance the body's immune function of tumor to destroy cancer cells peripheral protective factor, so that cancer cells will be damaged easily. Pre-vitro experiments, the cardamom extract can inhibit the proliferation of human gastric adenocarcinoma SGC-7901 cells. The experiment through the establishment of the nude mice with gastric adenocarcinoma cell line SGC-7901 subcutaneous xenograft model, research cardamom extract combined with 5-FU on human gastric cancer cells transplanted into nude mice growth, and to explore its possible mechanism, and thus for cardamom extract as an anti-gastric cancer drugs used clinically to provide the preliminary experiments basis. [] This topic vitro cell culture of human gastric carcinoma cell line SGC-7901, and the establishment of human gastric cancer cells in subcutaneous xenograft model, will become the 24 experimental tumor bearing mice were randomly divided into four groups of six each. Control group: given phosphate-buffered saline (PBS solution) 0.2ml orally, once / day for four weeks; PBS liquid 0.2ml intraperitoneal injection every other day, a total of seven. The the cardamom extract group: given the cardamom extract preparations 1g / (kg.d) orally, once / day for four weeks; PBS solution 0.2ml intraperitoneal injection every other day, a total of seven times. 5-FU group: given 0.2 ml of PBS was orally, once / day for four weeks; 5-FU 20mg / (kg.d) by intraperitoneal injection, every other day, a total of seven times. Combined group (the cardamom extract 5-FU): given the the cardamom extract preparation 1g / (kg.d) orally once / day for four weeks; 5-FU20mg / (kg.d) by intraperitoneal injection, every other day, a total of seven times. The daily observation of the general situation of the nude, measurement of subcutaneous tumor size and weight of nude mice, drawing tumor growth and animal average weight time graph. After the end of the experiment, nude mice were sacrificed, measuring the volume of transplanted into nude mice, known as tumor weight calculated the rate of tumor weight inhibition, HE staining of tumor morphological characteristics. Immunohistochemical method detection groups transplant in tumor cyclooxygenase -2 (COX-2) and vascular endothelial growth factor (VEGF) protein expression; CD34 marker of vascular endothelial cells in tumor microvessel density (MVD) was measured. [Results] 1, successfully established gastric cancer transplanted into nude mice model. 2, after the end of the experiment, nude mice in the control group, the degree of weight loss significantly, and the cardamom extract group ,5-FU and combination groups, the difference was statistically significant (P lt; 0.05). 3, tumor volumes in each group: control group (1424.38 ± 188.62) mm3, cardamom extract group (800.52 ± 163.55) mm3 ,5-FU group for (574.21 ± 115.73) mm3, the combined group (322.65 ± 62.39) mm3. Tumor weight were: control group (1.822 ± 0.24) g, cardamom group (0.987 ± 0.20) g ,5-FU group (0.662 ± 0.12) g, (0.414 ± 0.09) g of the combined group. Cardamom extract group ,5-FU group can be seen, the average tumor weight of the combined group, tumor volume compared to the control group, the difference was statistically significant (P lt; 0.05). Joint group average tumor weight, tumor volume with cardamom extract and 5-FU, and the difference was statistically significant (P lt; 0.05). 4, each drug intervention in tumor weight inhibition rates were 63.67%: cardamom extract group 45.83% ,5-FU group, 77.28% of the combination group. 5, HE staining under light microscope to observe the tumor: control group transplanted tumor cells with typical morphological characteristics of malignant cells, namely large nuclei deeply stained, nuclear atypia, pathological split more common, the number of tumor cells, arranged disorders, blood Doufeng Fu. The the cardamom extract group and the 5-FU group is still visible morphological characteristics of the tumor cells, tumor cells relative reduction in the number of visible swelling of the tumor cell degeneration changes. Joint group of tumor cells were round or oval, lightly stained mitotic rare, significantly reduced the number of tumor cells can be seen more swelling of the tumor cells degeneration and necrosis, even large areas of necrosis, interstitial blood vessels to reduce. Immunohistochemistry showed: transplanted tumors, VEGF, COX-2 protein expression levels and MVD count cardamom extract Groups and combined group and the control group compared to the difference was statistically significant (P lt; 0.05). More significant to the combined group differences (P lt; 0.01). [Conclusion] 1, cardamom extract, 5-FU and their associated can inhibit the growth of human gastric cancer cells transplanted into nude mice, reducing tumor volume and weight. 2 cardamom extract and 5-FU both associated with more single group inhibit transplanted into nude mice growth, both associated with a synergistic effect. , Cardamom extract to inhibit the growth of human gastric carcinoma transplanted into nude mice mechanism may be lowered tumor foci of VEGF, COX-2 protein expression, reducing tumor foci MVD related.
|